tirzepatide ruling Update: On December 19th the FDA ruled the tirzepatide shortage was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On Compounding pharmacies can resume making

PlexusDx explains the clinical evidence for pre- and post-meal dosing strategies

This case raises concern about potential severe GI motility complications associated with Zepbound, particularly in the absence of conventional SBO risk factors.

Digital weight loss company Noom has entered the evolving GLP-1 medication landscape with the launch of its Noom Microdose GLP-1Rx Program, offering members personalized microdoses of GLP-1 medications combined with behavioral coaching and clinical support

For patients experiencing myalgia (muscle pain) due to tirzepatide, the recommended approach is to start with dose reduction and gradual titration while cont...